The Claude model from Anthropic has identified an unknown enzymatic system, similar to the molecular scissors of CRISPR. Its function remains to be clarified.
The artificial intelligence company Anthropic has announced that its Claude model has autonomously discovered a new enzyme system that acts on DNA. The discovery, made by analyzing vast genetic datasets, involves a sequence that had previously eluded human biologists.
According to the company, the enzyme system exhibits characteristics similar to the "molecular scissors" used in CRISPR technology, which was awarded the Nobel Prize in Chemistry in 2020. The precise function of this new system is not yet known and will be the task of human researchers, supported by AI, to uncover through laboratory testing.
Anthropic has shared the initial results to demonstrate to the scientific community Claude's capabilities in autonomously detecting anomalies and guiding analysis toward biological discoveries. The research was conducted by approximately 950 AI agents that examined 210 million tokens in 21 hours.
Artificial intelligence applied to biology represents a rapidly evolving frontier. Anthropic is a company specialized in developing advanced AI systems, including Claude, designed to analyze complex data. The announced discovery fits within this emerging technological context.
Traditional biological research relies on human analysis of genetic sequences, a process that can take years. AI accelerates this phase by identifying patterns and anomalies in vast databases that would escape researchers. The newly discovered system resembles Crispr technology, a revolutionary gene-editing technique discovered in 2012 that allows for precise cutting and modification of DNA.
This discovery demonstrates how AI can become an autonomous tool in scientific research, opening new possibilities while also raising ethical questions about machine autonomy. The next step will see biologists collaborating with Claude to understand the function of the new enzyme, potentially paving the way for new applications in medicine and biotechnology.
"Dentro la Notizia" (Inside the Story) is an amateur, non-profit section of quoz.it, created for people who find it hard to make sense of current affairs without some context. Articles are written with AI assistance from public sources, without a professional newsroom or systematic editorial review: they may contain inaccuracies and are not a substitute for registered news outlets. This is not a registered press outlet under Italian law (L. 62/2001). Images, when not original, come from external sources for illustrative purposes only. If you find an article offensive, inaccurate, or think it should not be published — or you hold rights to a text or image and want it removed — let us know and we will act promptly.
Contact:
info@quoz.it
Comments (0)
No comments yet. Write the first one!